These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7726506)

  • 61. Adhesion of Actinobacillus actinomycetemcomitans to a human oral cell line.
    Mintz KP; Fives-Taylor PM
    Infect Immun; 1994 Sep; 62(9):3672-8. PubMed ID: 8063383
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Frampton JE; Brogden RN; Langtry HD; Buckley MM
    Drugs; 1992 Nov; 44(5):889-917. PubMed ID: 1280571
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Electron immunocytochemical localization of Actinobacillus actinomycetemcomitans leukotoxin.
    Berthold P; Forti D; Kieba IR; Rosenbloom J; Taichman NS; Lally ET
    Oral Microbiol Immunol; 1992 Feb; 7(1):24-7. PubMed ID: 1528620
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clarithromycin accumulation by phagocytes and its effect on killing of Aggregatibacter actinomycetemcomitans.
    Iskandar I; Walters JD
    J Periodontol; 2011 Mar; 82(3):497-504. PubMed ID: 20932153
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Susceptibility of Neisseria gonorrhoeae to cefpodoxime: determination of MICs and disk diffusion zone diameters.
    Fekete T; Woodwell J; Cundy KR
    Antimicrob Agents Chemother; 1991 Mar; 35(3):497-9. PubMed ID: 1903910
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The sensitivity of 173 Sydney isolates of Neisseria gonorrhoeae to cefpodoxime and other antibiotics used to treat gonorrhea.
    Tapsall JW; Phillips EA
    Pathology; 1995 Jan; 27(1):64-6. PubMed ID: 7603756
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro activity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa, including beta-lactamase producers.
    Wiedemann B; Luhmer E; Zühlsdorf MT
    Infection; 1991; 19(5):363-9. PubMed ID: 1800378
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of tetracycline resistance in Actinobacillus actinomycetemcomitans.
    Roe DE; Braham PH; Weinberg A; Roberts MC
    Oral Microbiol Immunol; 1995 Aug; 10(4):227-32. PubMed ID: 8602335
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Membrane protein expression by Actinobacillus actinomycetemcomitans in response to iron availability.
    Winston JL; Chen CK; Neiders ME; Dyer DW
    J Dent Res; 1993 Oct; 72(10):1366-73. PubMed ID: 8408878
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin.
    Kalmar JR; Arnold RR
    Infect Immun; 1988 Oct; 56(10):2552-7. PubMed ID: 3417349
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.
    Limnios A; Tapsall J; Kahlmeter J; Hogan T; Ray S; Lam A; Unemo M
    APMIS; 2011 Jun; 119(6):356-63. PubMed ID: 21569093
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Opsonization of Actinobacillus actinomycetemcomitans by immunoglobulin G antibodies to the O polysaccharide of lipopolysaccharide.
    Wilson ME; Bronson PM
    Infect Immun; 1997 Nov; 65(11):4690-5. PubMed ID: 9353051
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pro-inflammatory cytokine responses in human gingival epithelial cells after stimulation with cell wall extract of Aggregatibacter actinomycetemcomitans subtypes.
    Pahumunto N; Chotjumlong P; Makeudom A; Krisanaprakornkit S; Dahlen G; Teanpaisan R
    Anaerobe; 2017 Dec; 48():103-109. PubMed ID: 28780429
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunoglobulin G subclass response of juvenile periodontitis subjects to principal outer membrane proteins of Actinobacillus actinomycetemcomitans.
    Wilson ME; Hamilton RG
    Infect Immun; 1995 Mar; 63(3):1062-9. PubMed ID: 7868228
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sensitivity of periodontal pathogens to the bactericidal activity of synthetic protegrins, antibiotic peptides derived from porcine leukocytes.
    Miyasaki KT; Iofel R; Lehrer RI
    J Dent Res; 1997 Aug; 76(8):1453-9. PubMed ID: 9240381
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Opsonic IgG antibody against Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.
    Baker PJ; Wilson ME
    Oral Microbiol Immunol; 1989 Jun; 4(2):98-105. PubMed ID: 2762021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Killing of Staphylococcus aureus by tumor necrosis factor-alpha-activated neutrophils. The role of serum opsonins, integrin receptors, respiratory burst, and degranulation.
    Ferrante A; Martin AJ; Bates EJ; Goh DH; Harvey DP; Parsons D; Rathjen DA; Russ G; Dayer JM
    J Immunol; 1993 Nov; 151(9):4821-8. PubMed ID: 8409440
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics.
    Müller HP; Holderrieth S; Burkhardt U; Höffler U
    J Clin Periodontol; 2002 Aug; 29(8):736-42. PubMed ID: 12390570
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In-vitro activity of cefpodoxime against pathogens responsible for community-acquired respiratory tract infections.
    Dabernat H; Avril JL; Boussougant Y
    J Antimicrob Chemother; 1990 Dec; 26 Suppl E():1-6. PubMed ID: 2127267
    [TBL] [Abstract][Full Text] [Related]  

  • 80. In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.
    Pavicić MJ; van Winkelhoff AJ; de Graaff J
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2634-8. PubMed ID: 1482130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.